A study on the pharmacological and biochemical profile of clocapramine.

M Kurihara, T Tsumagari, M Setoguchi, T Fukuda
{"title":"A study on the pharmacological and biochemical profile of clocapramine.","authors":"M Kurihara,&nbsp;T Tsumagari,&nbsp;M Setoguchi,&nbsp;T Fukuda","doi":"10.1159/000468561","DOIUrl":null,"url":null,"abstract":"<p><p>Clocapramine was introduced into clinical use as a successor to carpipramine which is designated as a \"désinhibiteur' by Deniker et al. Pharmacological and biochemical studies were carried out in order to elucidate the central action of clocapramine. Antidopaminergic activity of clocapramine was more potent than that of carpipramine. Clocapramine did not show any imipramine-like action; on the other hand, carpipramine partially did. We discuss the correlation between the preclinical findings so far obtained and clinical disinhibitory activity.</p>","PeriodicalId":75943,"journal":{"name":"International pharmacopsychiatry","volume":"17 2","pages":"73-90"},"PeriodicalIF":0.0000,"publicationDate":"1982-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1159/000468561","citationCount":"5","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International pharmacopsychiatry","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1159/000468561","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 5

Abstract

Clocapramine was introduced into clinical use as a successor to carpipramine which is designated as a "désinhibiteur' by Deniker et al. Pharmacological and biochemical studies were carried out in order to elucidate the central action of clocapramine. Antidopaminergic activity of clocapramine was more potent than that of carpipramine. Clocapramine did not show any imipramine-like action; on the other hand, carpipramine partially did. We discuss the correlation between the preclinical findings so far obtained and clinical disinhibitory activity.

氯氯帕明的药理学和生化特征研究。
氯卡普拉明被引入临床使用,作为卡布拉明的继任者,卡布拉明被Deniker等人指定为“dsamsinhibiteur”。为了阐明氯氯帕明的中心作用,进行了药理学和生化研究。氯克拉帕明的抗多巴胺能活性比卡比帕明更强。氯氯帕明未表现出类似丙咪嗪的作用;另一方面,卡哌胺有部分作用。我们讨论到目前为止获得的临床前发现与临床去抑制活性之间的关系。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书